Position in MRK
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$3,976,304
+$493,067 QoQ
Shares Held
30,944
+6.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.63%
of 13F equity value
Holder Rank
#1,151
of 3,769 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Kathmere Capital Management, LLC holds $38,480,404 across 14 Drug Manufacturers - General names. MRK ranks #3 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,204 | $11,734,429 | |
| 2 | LLY |
ELI LILLY & Co
|
4,626 | $5,548,563 | |
| 3 | MRK |
Merck & Co., Inc.
This page
|
30,944 | $3,976,304 | |
| 4 | NVS |
Novartis AG
|
22,990 | $3,602,992 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
26,787 | $3,384,269 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
37,197 | $2,143,291 | |
| 7 | ABBV |
AbbVie Inc.
|
7,045 | $1,772,803 | |
| 8 | BIIB |
Biogen Inc.
|
7,285 | $1,573,997 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,976,304 | 30,944 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $3,483,237 | 28,957 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,729,707 | 25,933 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $1,795,514 | 21,393 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,567,526 | 19,802 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $1,790,801 | 19,951 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $2,036,753 | 20,474 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $2,374,766 | 20,912 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $2,551,146 | 20,607 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $2,578,962 | 19,545 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $2,130,795 | 19,545 | Shares | Sole | 2024-04-16 | |
| 2023-09-30 | $1,984,052 | 19,272 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $2,014,940 | 17,462 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $1,698,835 | 15,968 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,866,400 | 16,822 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $1,373,958 | 15,954 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $1,238,270 | 13,582 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,021,194 | 12,446 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $729,152 | 9,514 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $805,930 | 10,730 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $857,258 | 11,023 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $779,380 | 10,110 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $342,414 | 4,186 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $311,062 | 3,750 | Shares | Sole | 2020-11-20 | |
| No filing history on record for this holder in this stock. | ||||||